This is going to be interesting. Drug wholesaling is a tough business with razor thin margins. Wholesalers don't make much off of branded drugs because the big drug companies have most of the negotiating power. It's not unusual for their cut to be in the tens of basis points. They make the most money off of generic drugs and often use arbitrage as a revenue source when price increases happen. Price increases for gene…
If an industry can be described in these terms, it's likely that Amazon is a potential entrant.